Insider · CIK 0001741973
Joe Bonaccorso
Files at VRCA (Verrica Pharmaceuticals Inc.). First filing Nov 16, 2023, latest Aug 28, 2024.
In brief
Joe Bonaccorso files SEC Form 4 as officer at VRCA (Verrica Pharmaceuticals Inc.). Since Nov 16, 2023, Joe Bonaccorso has reported 0 open-market buys worth $0 and 3 open-market sells worth $365k, the latest filed on Aug 28, 2024.
A track record needs three past buys with six months of prices behind them; Joe Bonaccorso has 0, so none is measured yet.
The newest scored trade: sold $88k of VRCA on Aug 26, 2024, filed Aug 28, 2024, scored 49 (moderate).
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
VRCA: Verrica Pharmaceuticals Inc.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 49Moderate | Verrica Pharmaceuticals Inc. | $88k 33,702 shares | -32% | 0% from low-73% from high | |
| 47Moderate | Verrica Pharmaceuticals Inc. | $181k 25,576 shares | -19% | +141% from low-26% from high | |
| 50Moderate | Verrica Pharmaceuticals Inc. | $97k 32,846 shares | -26% | +29% from low-66% from high |
Planned sales
Form 144 notices this insider filed before selling restricted or control stock, newest first.
| Filed | Company | Shares | Value | Sale date | Past 3 months |
|---|---|---|---|---|---|
| Aug 26, 2024 | VRCA Verrica Pharmaceuticals Inc. | 34,000 0.08% of outstanding | $90k | Aug 26, 2024 | $180k |
| Jul 22, 2024 | VRCA Verrica Pharmaceuticals Inc. | 25,840 0.06% of outstanding | $180k | Jul 22, 2024 | none |
| Nov 15, 2023 | VRCA Verrica Pharmaceuticals Inc. | 32,943 0.08% of outstanding | $97k | Nov 14, 2023 | none |
Transactions
Every row this insider has filed, 8 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Aug 26, 2024 | VRCA Verrica Pharmaceuticals Inc. | SOpen-market sale Common Stock | -24,709 | $2.66 | $66k | 82,107 | Aug 28, 2024 |
| Aug 27, 2024 | VRCA Verrica Pharmaceuticals Inc. | SOpen-market sale Common Stock | -8,993 | $2.46 | $22k | 73,114 | Aug 28, 2024 |
| Jul 22, 2024 | VRCA Verrica Pharmaceuticals Inc. | SOpen-market sale Common Stock | -25,461 | $7.06 | $180k | 106,931 | Jul 23, 2024 |
| Jul 23, 2024 | VRCA Verrica Pharmaceuticals Inc. | SOpen-market sale Common Stock | -115 | $6.98 | $803 | 106,816 | Jul 23, 2024 |
| Mar 15, 2024 | VRCA Verrica Pharmaceuticals Inc. | AGrant or award Common Stock | +40,000 | $0.00 | $0 | 132,392 | Mar 19, 2024 |
| Mar 15, 2024 | VRCA Verrica Pharmaceuticals Inc. | AGrant or award Employee Stock Option (right to buy)derivative | +80,000 | $0.00 | $0 | 80,000 | Mar 19, 2024 |
| Nov 14, 2023 | VRCA Verrica Pharmaceuticals Inc. | SOpen-market sale Common Stock | -21,580 | $2.93 | $63k | 103,658 | Nov 16, 2023 |
| Nov 15, 2023 | VRCA Verrica Pharmaceuticals Inc. | SOpen-market sale Common Stock | -11,266 | $2.97 | $33k | 92,392 | Nov 16, 2023 |
Questions about Joe Bonaccorso
Answered from the filings on this page, as of the latest one.
Is Joe Bonaccorso buying or selling?
Not in the last 12 months. Joe Bonaccorso's latest open-market trade on SEC Form 4 was sold $88k of VRCA on Aug 26, 2024.
How did Joe Bonaccorso's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Joe Bonaccorso has 0.
Where does Joe Bonaccorso file Form 4?
Joe Bonaccorso has filed Form 4 at VRCA (Verrica Pharmaceuticals Inc.) as CHIEF COMMERCIAL OFFICER. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.